We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
226
ResMed
RMD
$34.2B
$6.6M 0.07%
34,454
-12,552
-27% -$2.55M
MCHP icon
227
Microchip Technology
MCHP
$40.7B
$6.57M 0.07%
71,801
-34,725
-33% -$3.18M
CCI icon
228
Crown Castle
CCI
$32B
$6.56M 0.07%
67,194
-5,314
-7% -$523K
MRO
229
DELISTED
Marathon Oil Corporation
MRO
$6.55M 0.07%
228,527
-3,375
-1% -$93.6K
NSC icon
230
Norfolk Southern
NSC
$78.3B
$6.52M 0.07%
30,390
-267
-0.9% -$62K
TSN icon
231
Tyson Foods
TSN
$19.5B
$6.51M 0.07%
113,928
-179
-0.2% -$10.5K
CPAY icon
232
Corpay
CPAY
$26.7B
$6.49M 0.07%
24,370
-149
-0.6% -$42.2K
YUM icon
233
Yum! Brands
YUM
$41.5B
$6.47M 0.07%
48,871
-12,786
-21% -$1.76M
CBRE icon
234
CBRE Group
CBRE
$43B
$6.47M 0.07%
72,591
+15,863
+28% +$1.41M
TRV icon
235
Travelers Companies
TRV
$77.7B
$6.46M 0.07%
31,786
-1,248
-4% -$268K
JCI icon
236
Johnson Controls International
JCI
$86.4B
$6.46M 0.07%
97,215
-2,913
-3% -$196K
O icon
237
Realty Income
O
$58.7B
$6.39M 0.07%
121,070
-9
-0% -$481
RCL icon
238
Royal Caribbean
RCL
$76.4B
$6.37M 0.07%
39,957
+1,521
+4% +$219K
ALL icon
239
Allstate
ALL
$65.2B
$6.37M 0.07%
39,871
+3,437
+9% +$573K
HUM icon
240
Humana
HUM
$47.2B
$6.33M 0.06%
16,954
-5,554
-25% -$1.88M
CNC icon
241
Centene
CNC
$32.4B
$6.31M 0.06%
95,196
-3,720
-4% -$271K
TRGP icon
242
Targa Resources
TRGP
$62.1B
$6.3M 0.06%
48,956
+216
+0.4% +$25.3K
GEV icon
243
GE Vernova
GEV
$252B
$6.25M 0.06%
+36,466
New +$5.78M
IR icon
244
Ingersoll Rand
IR
$30.8B
$6.21M 0.06%
68,376
-6,386
-9% -$587K
SPOT icon
245
Spotify
SPOT
$110B
$6.17M 0.06%
19,655
+472
+2% +$142K
LHX icon
246
L3Harris
LHX
$49B
$6.16M 0.06%
27,438
+1,451
+6% +$314K
KMI icon
247
Kinder Morgan
KMI
$70.5B
$6.08M 0.06%
305,825
-5,343
-2% -$102K
DASH icon
248
DoorDash
DASH
$101B
$6.07M 0.06%
55,793
+7,148
+15% +$861K
PWR icon
249
Quanta Services
PWR
$93.1B
$6.02M 0.06%
23,698
+1,007
+4% +$267K
DVN icon
250
Devon Energy
DVN
$52.3B
$6.02M 0.06%
126,955
-2,568
-2% -$128K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.